Australia markets closed

Mindset Pharma Inc. (MSSTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2122-0.0028 (-1.28%)
At close: 01:21PM EST

Mindset Pharma Inc.

217 Queen Street West
Suite 401
Toronto, ON M5V 0R2

Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. James Andre-Charles LanthierChief Exec. Officer357.8k37.46k1975
Mr. Arvin Ramos CPAChief Financial Officer87.69kN/A1979
Mr. Joseph AraujoChief Scientific Officer, Member of Scientific Advisory Board & Director258.72kN/A1977
Mr. Jason AtkinsonVP of Corp. Devel.112.44kN/A1988
Dr. Abdelmalik Slassi Ph.D.Sr. VP of Innovation & Member of Scientific Advisory Board352.29kN/AN/A
Chris IrwinCorp. Sec.N/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.

Corporate governance

Mindset Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.